59 results
S-8
ORIC
ORIC Pharmaceuticals Inc
29 Mar 24
Registration of securities for employees
4:47pm
officers and directors for liabilities (including reimbursement of expenses incurred) arising under the Securities Act.
Item 7. Exemption from
8-K
EX-10.1
ORIC
ORIC Pharmaceuticals Inc
29 Mar 24
Departure of Directors or Certain Officers
4:15pm
that the Participant’s rights, payments, and benefits with respect to an Award will be subject to reduction, cancellation, forfeiture, recoupment, reimbursement
S-3ASR
ORIC
ORIC Pharmaceuticals Inc
11 Mar 24
Automatic shelf registration
5:28pm
that may be necessary or desirable to develop, manufacture or commercialize our product candidates;
the pricing and reimbursement of ORIC-114, ORIC-944 … for the offering, excluding any commissions or expense reimbursement payable to Jefferies under the terms of the sales agreement
8-K
EX-99.1
z6ppubzl z8e5
9 Jan 24
Results of Operations and Financial Condition
9:00am
S-3
sj9j joi5jwxyhonbnlb
15 Dec 23
Shelf registration
4:32pm
424B5
5dv66i5v72aa
21 Dec 22
Prospectus supplement for primary offering
5:23pm
S-8
l9pih2
22 Mar 22
Registration of securities for employees
4:11pm